Angiotensin converting enzyme inhibitors versus receptor blockers in patients with ventricular tachyarrhythmias

Data investigating the prognostic value of treatment with angiotensin converting enzyme inhibitors (ACEi) and receptor blockers (ARB) usually focusses on patients presenting with heart failure (HF) or acute myocardial infarction (AMI). However, by preventing adverse cardiac remodeling, ACEi/ARB may...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schupp, Tobias (VerfasserIn) , Behnes, Michael (VerfasserIn) , Abumayyaleh, Mohammad S. A. (VerfasserIn) , Weidner, Kathrin (VerfasserIn) , Mashayekhi, Kambis (VerfasserIn) , Bertsch, Thomas (VerfasserIn) , Akın, Ibrahim (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 7 March 2022
In: Journal of Clinical Medicine
Year: 2022, Jahrgang: 11, Heft: 5, Pages: 1-11
ISSN:2077-0383
DOI:10.3390/jcm11051460
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/jcm11051460
Verlag, kostenfrei, Volltext: https://www.mdpi.com/2077-0383/11/5/1460
Volltext
Verfasserangaben:Tobias Schupp, Michael Behnes, Mohammad Abumayyaleh, Kathrin Weidner, Kambis Mashayekhi, Thomas Bertsch and Ibrahim Akin

MARC

LEADER 00000caa a2200000 c 4500
001 1887420274
003 DE-627
005 20250116225838.0
007 cr uuu---uuuuu
008 240430s2022 xx |||||o 00| ||eng c
024 7 |a 10.3390/jcm11051460  |2 doi 
035 |a (DE-627)1887420274 
035 |a (DE-599)KXP1887420274 
035 |a (OCoLC)1443669762 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schupp, Tobias  |d 1995-  |e VerfasserIn  |0 (DE-588)1168611091  |0 (DE-627)103237862X  |0 (DE-576)51163840X  |4 aut 
245 1 0 |a Angiotensin converting enzyme inhibitors versus receptor blockers in patients with ventricular tachyarrhythmias  |c Tobias Schupp, Michael Behnes, Mohammad Abumayyaleh, Kathrin Weidner, Kambis Mashayekhi, Thomas Bertsch and Ibrahim Akin 
246 1 |i Titel des übergeordneten Special issue  |a Sudden cardiac death: clinical updates and perspectives 
264 1 |c  7 March 2022 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 30.04.2024 
520 |a Data investigating the prognostic value of treatment with angiotensin converting enzyme inhibitors (ACEi) and receptor blockers (ARB) usually focusses on patients presenting with heart failure (HF) or acute myocardial infarction (AMI). However, by preventing adverse cardiac remodeling, ACEi/ARB may also decrease the risk of ventricular tachyarrhythmias and sudden cardiac death (SCD). Although ventricular tachyarrhythmias are associated with significant mortality and morbidity, only limited data are available focusing on the prognostic role of ACEi/ARB, when prescribed for secondary prevention of SCD. Therefore, this study comprehensively investigates the role of ACEi versus ARB in patients with ventricular tachyarrhythmias. A large retrospective registry was used including consecutive patients with episodes of ventricular tachycardia (VT) or fibrillation (VF) from 2002 to 2015. The primary prognostic outcome was all-cause mortality at three years, secondary endpoints comprised a composite arrhythmic endpoint (i.e., recurrences of ventricular tachyarrhythmias, ICD therapies and sudden cardiac death) and cardiac rehospitalization. A total of 1236 patients were included (15% treated with ARB and 85% with ACEi) and followed for a median of 4.0 years. At three years, ACEi and ARB were associated with comparable long-term mortality (20% vs. 17%; log rank p = 0.287; HR = 0.965; 95% CI 0.689-1.351; p = 0.835) and comparable risk of the composite arrhythmic endpoint (HR = 1.227; 95% CI 0.841-1.790; p = 0.288). In contrast, ACEi was associated with a decreased risk of cardiac rehospitalization at three years (HR = 0.690; 95% CI 0.490-0.971; p = 0.033). Within the propensity score matched cohort (i.e., 158 patients with ACEi and ARB), ACEi and ARB were associated with comparable long-term outcomes at three years. In conclusion, ACEi and ARB are associated with comparable risk of long-term outcomes in patients presenting with ventricular tachyarrhythmias. 
650 4 |a ACE inhibitor 
650 4 |a ARB 
650 4 |a medical treatment 
650 4 |a mortality 
650 4 |a pharmacological drugs 
650 4 |a ventricular fibrillation 
650 4 |a ventricular tachycardia 
700 1 |a Behnes, Michael  |d 1982-  |e VerfasserIn  |0 (DE-588)138373361  |0 (DE-627)696560518  |0 (DE-576)307333949  |4 aut 
700 1 |a Abumayyaleh, Mohammad S. A.  |d 1990-  |e VerfasserIn  |0 (DE-588)1215107617  |0 (DE-627)172611743X  |4 aut 
700 1 |a Weidner, Kathrin  |d 1985-  |e VerfasserIn  |0 (DE-588)1156687470  |0 (DE-627)1019523891  |0 (DE-576)502375027  |4 aut 
700 1 |8 1\p  |a Mashayekhi, Kambis  |d 1977-  |e VerfasserIn  |0 (DE-588)1160238790  |0 (DE-627)1023385430  |0 (DE-576)505789124  |4 aut 
700 1 |a Bertsch, Thomas  |e VerfasserIn  |0 (DE-588)105441193X  |0 (DE-627)791504999  |0 (DE-576)410254835  |4 aut 
700 1 |a Akın, Ibrahim  |d 1978-  |e VerfasserIn  |0 (DE-588)132322293  |0 (DE-627)521039010  |0 (DE-576)299074366  |4 aut 
773 0 8 |i Enthalten in  |t Journal of Clinical Medicine  |d Basel : MDPI, 2012  |g 11(2022), 5, Artikel-ID 1460, Seite 1-11  |h Online-Ressource  |w (DE-627)718632478  |w (DE-600)2662592-1  |w (DE-576)365782718  |x 2077-0383  |7 nnas  |a Angiotensin converting enzyme inhibitors versus receptor blockers in patients with ventricular tachyarrhythmias 
773 1 8 |g volume:11  |g year:2022  |g number:5  |g elocationid:1460  |g pages:1-11  |g extent:11  |a Angiotensin converting enzyme inhibitors versus receptor blockers in patients with ventricular tachyarrhythmias 
856 4 0 |u https://doi.org/10.3390/jcm11051460  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2077-0383/11/5/1460  |x Verlag  |z kostenfrei  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20240430 
993 |a Article 
994 |a 2022 
998 |g 132322293  |a Akın, Ibrahim  |m 132322293:Akın, Ibrahim  |d 60000  |d 61000  |e 60000PA132322293  |e 61000PA132322293  |k 0/60000/  |k 1/60000/61000/  |p 7  |y j 
998 |g 105441193X  |a Bertsch, Thomas  |m 105441193X:Bertsch, Thomas  |d 60000  |d 63300  |e 60000PB105441193X  |e 63300PB105441193X  |k 0/60000/  |k 1/60000/63300/  |p 6 
998 |g 1156687470  |a Weidner, Kathrin  |m 1156687470:Weidner, Kathrin  |p 4 
998 |g 1215107617  |a Abumayyaleh, Mohammad S. A.  |m 1215107617:Abumayyaleh, Mohammad S. A.  |d 60000  |e 60000PA1215107617  |k 0/60000/  |p 3 
998 |g 138373361  |a Behnes, Michael  |m 138373361:Behnes, Michael  |d 60000  |d 61000  |e 60000PB138373361  |e 61000PB138373361  |k 0/60000/  |k 1/60000/61000/  |p 2 
998 |g 1168611091  |a Schupp, Tobias  |m 1168611091:Schupp, Tobias  |d 60000  |e 60000PS1168611091  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1887420274  |e 4519324882 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1887420274"],"doi":["10.3390/jcm11051460"]},"name":{"displayForm":["Tobias Schupp, Michael Behnes, Mohammad Abumayyaleh, Kathrin Weidner, Kambis Mashayekhi, Thomas Bertsch and Ibrahim Akin"]},"titleAlt":[{"title":"Sudden cardiac death: clinical updates and perspectives"}],"title":[{"title_sort":"Angiotensin converting enzyme inhibitors versus receptor blockers in patients with ventricular tachyarrhythmias","title":"Angiotensin converting enzyme inhibitors versus receptor blockers in patients with ventricular tachyarrhythmias"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"note":["Gesehen am 30.04.2024"],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":" 7 March 2022"}],"relHost":[{"pubHistory":["1.2012 -"],"origin":[{"dateIssuedKey":"2012","publisherPlace":"Basel","dateIssuedDisp":"2012-","publisher":"MDPI"}],"part":{"pages":"1-11","issue":"5","text":"11(2022), 5, Artikel-ID 1460, Seite 1-11","extent":"11","year":"2022","volume":"11"},"title":[{"subtitle":"open access journal","title_sort":"Journal of Clinical Medicine","title":"Journal of Clinical Medicine"}],"id":{"zdb":["2662592-1"],"issn":["2077-0383"],"eki":["718632478"]},"note":["Gesehen am 12.06.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"recId":"718632478","physDesc":[{"extent":"Online-Ressource"}],"disp":"Angiotensin converting enzyme inhibitors versus receptor blockers in patients with ventricular tachyarrhythmiasJournal of Clinical Medicine"}],"person":[{"family":"Schupp","role":"aut","given":"Tobias","display":"Schupp, Tobias"},{"family":"Behnes","role":"aut","given":"Michael","display":"Behnes, Michael"},{"family":"Abumayyaleh","given":"Mohammad S. A.","role":"aut","display":"Abumayyaleh, Mohammad S. A."},{"display":"Weidner, Kathrin","family":"Weidner","role":"aut","given":"Kathrin"},{"family":"Mashayekhi","given":"Kambis","role":"aut","display":"Mashayekhi, Kambis"},{"family":"Bertsch","role":"aut","given":"Thomas","display":"Bertsch, Thomas"},{"family":"Akın","given":"Ibrahim","role":"aut","display":"Akın, Ibrahim"}],"recId":"1887420274","physDesc":[{"extent":"11 S."}]} 
SRT |a SCHUPPTOBIANGIOTENSI7202